Reference Citation Analysis: Find an Article, Find a Category, Find a Journal, Find a Scholar

Total Articles

1
(from Reference Citation Analysis)

Article PDFs (1)

Cited by > 0 (1)

Searched Name

AKT/GSK‑3β/Snail signaling

Ranked By

Results Analysis

Results Analysis

Indexed Articles

Year Published

Show more Refine

Article Statistics

Refine

Publication Titles

Show more Refine

Grant Agencies

Show more Refine

Category

Show more Refine

Number	Citation Analysis
1	[Corrigendum] Resveratrol inhibits the invasion and metastasis of colon cancer through reversal of epithelial‑mesenchymal transition via the AKT/GSK‑3β/Snail signaling pathway. Mol Med Rep 2022;26:354. [PMID: 36222306 PMCID: PMC9579835 DOI: 10.3892/mmr.2022.12870] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/11/2019] [Accepted: 06/06/2019] [Indexed: 11/29/2022] Open Abstract Collapse Key Words AKT/GSK‑3β/Snail signaling colon cancer epithelialmesenchymal transition metastasis resveratrol Collapse MESH Headings Collapse Grants Collapse

Number

Citation Analysis

[Corrigendum] Resveratrol inhibits the invasion and metastasis of colon cancer through reversal of epithelial‑mesenchymal transition via the AKT/GSK‑3β/Snail signaling pathway. Mol Med Rep 2022;26:354. [PMID: 36222306 PMCID: PMC9579835 DOI: 10.3892/mmr.2022.12870] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/11/2019] [Accepted: 06/06/2019] [Indexed: 11/29/2022] Open